Optimization of a meprobamate fast released tablet formulation using mixture design

Latin American Journal of Pharmacy

Volumn 27, Issue 1, 2008, Pages 62-67

  Fernández Cervera, Mirna ^a   Marín, Yamila Lisandra ^a   Fernández, Eutimio G ^b   Pérez Sánchez, Irela ^a   Jiménez Cuellar, Bárbara ^c  

^a UNIVERSITY OF HAVANA   (Cuba)

^b Center for Engineering and Chemical Researches   (Cuba)

^c Novatec Laboratories   (Cuba)

Author keywords

D optimal mixture design; Drug dissolution; Fast release tablets; Meprobamate; Optimization of tablet formulation

Indexed keywords

CROSCARMELLOSE SODIUM; DODECYL SULFATE SODIUM; MEPROBAMATE; STARCH;

ARTICLE; DRUG DETERMINATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; EXPERIMENTAL DESIGN; MAIZE; TABLET FORMULATION;

EID: 43049119628     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Frey, H. & I. Bartels (1997) Epilepsy Res. 27: 151-64.
2. Meyler, L. & A. Herxheimer (1968) Side effects of drugs, Vol. VI, Exerpta Medica, Amsterdam.
3. Rall, T.W. (1990) "Hypnotics and sedatives: ethanol" In "The Pharmacological Basis of Therapeutics" (A. Goodman Gilman, T.W. Rall, A.S. Nies & P. Taylor, eds.), 8th Edn., Pergamon Press, New York, págs. 345-82.
4. Lavit, M., S. Saivin & G. Houin (2000) Rev. Fr. Laborat. 322: 61-3.
5. USP 27 (2004) Meprobamate Oral Suspension. Meprobamate Tablets. The United States Pharmacopoeial Convention Inc., pág. 1167.
6. Zhang, G.G.Z., D. Lawa, E.A. Schmittb & Y.Qiu (2004) Adv. Drug Deliv. Rev. 56: 371-90.
7. Furlanetto, S., M. Cirri, F. Maestrelli, G. Corti &P. Mura (2006) Eur. J. Pharm. Biopharm. 62: 77-84.
8. Martinello, T., T.M. Kaneko, M.V. Robles Velasco, M.E. Santos Taqueda & V.O. Consiglieri (2006) Int. J. Pharm. 322: 87-95.
9. Gabrielsson, J., N.O. Lindberg & T. Lundstedt (2002) J. Chemometr. 16: 141-60.
10. Bodea, A. & S.E. Leucuta (1997) Int. J. Pharm. 153: 247-55
11. Huang, Y.-B., Tsai, Y.-H., Lee, S.-H., Chang, J.-S. & Wu, P.-C. (2005) Int. J. Pharm. 289: 87-95
12. Huang, Y.-B., Y.-H.Tsai, S.-H. Lee, J.-S. Chang & P.-C. Wu (2005) Int. J. Pharm. 289: 87-95.
13. Perissutti, B., F. Rubessa, M. Moneghini & D.Voinovich (2003) Int. J. Pharm. 256: 53-63.
14. Cafaggi, S., R. Leardi, B. Parodi, G. Caviglioli &G. Bignardi (2003) Chemometr. Intell. Lab. Syst. 65: 139-47.
15. Iraizoz, A., O. Bilbao & M.A. Barrios (1990) "Conferencias de Tecnología Farmacéutica II". Facultad de Farmacia y Alimentos. Departamento de Tecnología y Control de Medicamentos. Universidad de La Habana, ENPES, Ciudad Habana, págs. 170-181.
16. Eriksson, L., E. Johansson & C. Wikströn (1998) Chemometr. Intell. Lab. Syst. 43: 1-24.
17. Antikainen, O. (2003) "New methods to evaluate applicability of powders and granules for tablet compression". Pharmaceutical Technology Division. Department of Pharmacy. Universityof Helsinki. Finland, págs. 3-4
18. York, P. (1980) Int. J. Pharm 6: 89-117